Structural and functional studies of mRNA processing, stability and quality control

NIH RePORTER · NIH · R35 · $25,757 · view on reporter.nih.gov ↗

Abstract

 DESCRIPTION (provided by applicant): Most eukaryotic messenger RNA precursors (pre-mRNAs) must undergo extensive co- transcriptional processing in the nucleus before they can be exported to the cytoplasm and function as mRNAs. The processing events include 5ʹ′-end capping, splicing, and 3ʹ′- end cleavage and polyadenylation. The 3'-end processing of most pre-mRNAs requires a large number of protein factors for its execution, including cleavage and polyadenylation specificity factor (CPSF), cleavage stimulation factor (CstF), cleavage factors I and II, and poly(A) polymerase (PAP). The 3'-end processing machinery in yeast has similarity to that in mammals, although there are also significant differences. Replication-dependent histone pre-mRNAs contain a conserved stem-loop near their 3ʹ′- end and employ a distinct machinery for its processing, although it shares some protein factors with the canonical pre-mRNA 3ʹ′-end processing machinery. mRNA 5ʹ′-end capping occurs early during transcription by RNA polymerase II, and it was generally believed that capping always proceeds to completion. We have recently discovered that the Rai1/DXO family of proteins are part of a mRNA capping quality surveillance mechanism. They can possess RNA 5ʹ′-end pyrophosphohydrolase (PPH) and decapping activities, and help remove incompletely capped mRNAs from cells. Despite the extensive studies on these mRNA processing and quality control factors, significant gaps remain in our knowledge of their molecular mechanisms of action. We will carry out structural studies on the protein factors and their complexes, and assess the structural observations by careful biochemical and functional experiments. The proposed project will greatly enhance our understanding of these important events in mRNA lifecycle.

Key facts

NIH application ID
10118922
Project number
3R35GM118093-04S2
Recipient
COLUMBIA UNIV NEW YORK MORNINGSIDE
Principal Investigator
LIANG TONG
Activity code
R35
Funding institute
NIH
Fiscal year
2020
Award amount
$25,757
Award type
3
Project period
2020-02-01 → 2021-04-30